Allspring Global Investments
BHVN

Allspring Global Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Allspring Global Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-287,350
Closed -$43.4M – 2993
2022
Q3 		$43.4M Sell
287,350
-623,542
-68% -$92.4M 0.08% 343
2022
Q2 		$133M Sell
910,892
-1,382,951
-60% -$177M 0.22% 115
2022
Q1 		$272M Buy
2,293,843
+756,363
+49% +$94.3M 0.34% 49
2021
Q4 		$212M Buy
+1,537,480
New +$196M 0.24% 98

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Allspring Global Investments's BHVN Position: Q4 2022 in Review

Allspring Global Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 287,350 shares — an estimated $43.4M sold.

Allspring Global Investments first reported a position in BHVN in Q4 2021 and held it in 4 quarters. The position peaked at $272M in Q1 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Allspring Global Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 287,350 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $43.4M.
  • Allspring Global Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $272M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.